Purpose of Review Multiple electronic devices exist that provide feedback on the accuracy of patient inhaler technique. Our purpose is to describe the inhaler technique feedback provided by these devices, including specific technique steps measured, how feedback is displayed, target of feedback (patient, provider, researcher), and compatibility with inhaler type (metered-dose inhaler [MDI], diskus, etc.). Recent Findings We identified eight devices that provide feedback on inhaler technique. Only one device assessed all evidence-based MDI technique steps. Most devices provide limited real-time feedback to patients, if any feedback at all. Summary Technologies to assess inhaler technique are advancing and hold great potential for improving patient inhaler technique. Many devices are limited in their ability to detect all evidence-based technique steps and provide real-time user-friendly feedback to patients and providers. Usability tests with patients and providers could identify ways to improve these devices to improve their utility in clinical settings.
Introduction
Asthma is projected to affect 400 million people worldwide by 2025 [1] and currently affects more than 25 million people in the USA [2] . The economic burden of asthma is substantial, having been estimated at $56 billion per year in direct and indirect costs [3] . Individuals with poorly controlled asthma have greater medical expenditures, use health services more often, and report more negative impact on work/school life and psychological health than individuals with controlled asthma [4, 5] .
Asthma control can be improved, and costly negative sequelae can be prevented when patients take medications appropriately [6] [7] [8] . Unfortunately, many asthma interventions that target medication use focus exclusively on medication adherence or give minimal attention to inhaler technique, also referred to as inhaler competence [9••] . Because improper technique can compromise delivery of inhaled medications to the lungs [10] , patients with incorrect technique are significantly more likely to have poorly controlled asthma and more emergency department visits [11] [12] [13] . The potential for inhaler technique interventions to improve asthma outcomes is substantial given that up to 92% of children [14] [15] [16] and 96% of adults [17, 18] with asthma demonstrate significant deficiencies in inhaler technique.
Due to a number of barriers, including time constraints and an increasing number of new inhaler devices on the market, providers often do not educate patients about how to use inhalers correctly during office visits [14] . Teach-back instruction, where patients explain or demonstrate how to use their inhaler after their provider instructs them on how to use it correctly, has been proven to improve patient technique but This article is part of the Topical Collection on Allergies and the Environment * Delesha M. Carpenter dmcarpenter@unc.edu is rarely implemented in practice [14, 19, 20] . New electronic devices could provide a more streamlined and standardized method to educate patients about how to use their asthma inhalers in clinical settings. Indeed, two review articles have documented that several digital inhaler monitoring devices are available to assess inhaler technique [9••, 21] . These reviews have documented that digital devices can validly and reliably assess patient inhaler technique, especially as it relates to inhalation maneuvers. However, these reviews are either outdated (published in 2010) or lack details about the specific technique steps assessed by the devices and the manner in which technique feedback is presented to providers and patients.
Our purpose was to update and enhance previous research to describe the nature of inhaler technique feedback provided by electronic devices, with a focus on factors that could influence the utility and uptake of these devices in clinical settings. We specifically focus on (a) the specific technique steps assessed by the device, (b) how feedback is presented, (c) target of feedback (patient, clinician, researcher), (d) compatibility with inhaler type (metered-dose inhaler [MDI] , diskus, other dry powder inhalers [DPIs]), (e) cost, and (f) whether the device is approved by the US Food and Drug Administration (FDA).
Methods
A systematic review of the literature and patents was conducted in December 2016 to identify electronic devices capable of assessing inhaler technique. Figure 1 summarizes our review and selection process.
Search Strategy
We first used PubMed to identify articles that described digital inhaler-based devices. We used the same search terms as a recent review of digital inhaler-based health monitoring devices that was completed in August 2015 [9••] . In order to identify any new devices that may have been reported in the literature since August 2015, we searched English-language articles that were published between August 2015 and December 2016. The specific search terms used were as follows:
(("electronic" OR "monitoring" OR "sensing") AND "inhaler") OR ("Nebulizer Chronolog" OR "MDI Chronolog" OR "Aerosol Actuation Counter" OR "Turbuhaler Inhalation Computer" OR "Doser" OR "Electronic Diskhaler" OR "SmartMist" OR "MDILog" OR "Diskus Adherence Logger" OR "Smart Inhaler Tracker" OR "SmartTrack" OR "SmartDisk" OR "SmartTurbo" OR "SmartFlow" OR "SmartMat" OR "Inhaler Compliance Assessment Device" OR "INCA" OR "Asthmapolis" OR " P r o p e l l e r H e a l t h " O R " C h a m e l e o n " O R "SmartTouch" OR "MDI Acoustic Actuation Detector" OR "pMDI Datalogger" OR "Geckocap" OR "CareTRx" OR "Inspiromatic" OR "Sensohaler" OR "T-Haler")
In addition to the PubMed review, we examined references of important full-text articles for potentially missed devices and included relevant devices that were described in previous review articles [9••, 21] that were not captured in our PubMed search. These searches yielded 539 potentially relevant titles.
We also conducted a patent search in order to identify devices that have been developed or are currently in development to assess inhaler technique that may have not yet been published in the peer-reviewed literature. Patent searches were conducted using Thomson Innovation (http://info. thomsoninnovation.com), which includes multiple databases of patents and patent applications from the USA, Europe, World Intellectual Property Organization (WIPO), China, and several other geographies. The Derwent World Patents Index (DWPI) is accessible within the Thomson Innovation tool, enabling searching of English language abstracts from expert editorial staffers, with an indexing system and patent families that group inventions across geographic filings. Within these databases, we conducted a search of patent titles, abstracts, and claims of patents and patent applications from January 1988 to December 2016 using the following query:
((inhaler* OR inhalation) AND (asthma)) AND ((sensor* OR track* OR monitor* OR record* OR display* NEAR10 (use OR efficien* OR compliance)). This search yielded 125 potentially relevant patents.
Selection Criteria For the literature search, we reviewed the titles of the 539 articles for potential relevance. Titles that referenced (1) inhaler adherence and/or technique, (2) using an asthma monitoring device or sensor, or (3) the name and/or application of an inhaler-based monitoring device that was identified in previous reviews were selected for further abstract review (n = 31). To reduce bias, three authors (CR, AS, DC) individually reviewed these 31 abstracts and then met to reach consensus on which articles would be selected for full-text review. Of the 31 articles, 12 described devices that were capable of assessing at least one patient inhaler technique step and were selected for full-text review.
Patent searches resulted in 125 potentially relevant patents, which were reviewed for relevancy by a research analyst (AS). Using the same selection criteria as the literature review, the analyst reviewed the titles and abstracts for each patent and identified 18 patents for further full-text review by a second reviewer (DC). During full-text review of the 18 patents, both reviewers came to a consensus on which patents to include for data abstracting (n = 2).
Exclusion Criteria Devices identified during the literature search and patent review were excluded if (1) the device exclusively assessed medication adherence, (2) the device was developed to alter the manner in which the drug was delivered rather than to assess technique, (3) the device did not assess at least one essential inhaler technique step as defined by the Aerosol Drug Management Improvement (ADMIT) Team (see data extraction and analysis for more information on essential steps) [22] . Additionally, we excluded one patent result that duplicated a device that was identified during the literature search.
Data Extraction and Analysis
We extracted the following information for each device: (1) name of device, (2) inhaler technique steps the device assesses, (3) how inhaler technique feedback is displayed, (4) the target of inhaler technique feedback (patient, clinician, researcher), (5) device compatibility (MDI, diskus, other); (6) cost of device (in US dollars), and (7) whether the device is FDA approved (yes/no).
The specific steps assessed by each device was cross-checked against the list of essential technique steps for MDI and diskus as identified in a recent review of the inhaler technique literature by ADMIT [22] . According to ADMIT, the five essential steps for a MDI include (1) preparing the device (uncap, shake, and hold inhaler vertically), (2) breathing out completely, (3) placing teeth and lips around mouthpiece and press canister once while inhaling slowly and deeply, (4) breathing in slowly and deeply, and (5) holding breath for 5-10 s. The essential steps for a diskus are (1) preparing the device (uncap, load the inhaler); (2) turning away from the inhaler and breathing out completely; (3) placing teeth and lips around the mouthpiece to form a seal; (4) breathing in with one brisk, deep inhalation; and (5) holding the breath for 5 to 10 s or as long as possible. In order to ensure that our results were as complete as possible, we supplemented missing information from the article and patent search using one or more of the following strategies: (1) contacting the corresponding author of the article and/or device manufacturer (if known), (2) searching for the device's name on Google, and (3) searching for videos about the device on YouTube. Table 1 presents an overview of the eight devices included in the review.
Steps Assessed No devices were capable of assessing all essential technique steps for an MDI. One device, the inhaler compliance assessment device (INCA), assessed all five essential steps for a diskus [23] . Devices most commonly assessed steps related to patients' breathing patterns (i.e., timing, force, and length of inhalation and exhalation). Four devices (50%) had the ability to detect whether an MDI inhaler was shaken. Table 1 presents information about the specific steps assessed by each device.
How Feedback Displayed Feedback on inhaler technique was most commonly provided in real time in the form of colored green or red lights (three devices, 38%). Two devices provided real-time feedback in the form of digital displays that incentivized correct technique. For example, the T-haler showed a green dot moving into a "correct" box when the patient's inhalation was optimal. Two devices did not provide any real-time feedback; data were recorded, downloaded, and viewable in a spreadsheet.
Target of Feedback Three devices (38%) were targeted specifically to patients, 2 (25%) to clinicians, and 1 (12.5%) to researchers. One device (INCA) could be used by clinicians, researchers, and patients, but patients would need someone to help them interpret the meaning of the audio file to understand how the sound waves relate to technique steps. The aerosol inhalation monitor (AIM) is targeted for clinicians, but the nature of its feedback suggests that it could also be readily understood by patients. The SmartMist provides feedback on technique that is interpretable by both clinicians and patients.
Device Compatibility The majority of devices (6; 75%) were compatible with MDIs. Three devices [27, 28, 34] were compatible with MDIs and spacers. Fewer devices are compatible with DPIs. Specifically, two devices, the INCA [23] [24] [25] [26] and Mag-Flo [35] , are designed for use with a diskus. The Mag-Flo is also compatible with turbuhalers.
Cost Cost information was only available for three devices. The AIM costs US$450, the Mag-Flo costs US$37.50, and the pMDI datalogger costs US$35. 
Discussion
This review summarizes key aspects of devices that have been developed to assess patient inhaler technique. Although several devices are currently available to assess technique, many have limitations as it relates to providing feedback on all essential technique steps or displaying feedback to providers and patients in a user-friendly format. Few devices are available to assess technique for DPIs, especially turbuhalers and newer devices like Ellipta. Despite limitations with existing devices, there is significant opportunity to use these devices in clinical settings to instruct patients on proper use of their inhalers.
Currently, no device provides feedback on all essential inhaler technique steps for MDIs, and only one device provides feedback on all essential diskus steps. Although the MDI-compatible devices do not address all essential steps, they do provide feedback on the steps that are most difficult to assess with the naked eye (i.e., timing, force, and length of inhalation and exhalation). Many of these devices also provide feedback on whether the patient shook their inhaler, which is a commonly missed step [14, 21] . For these reasons, when coupled with feedback from a provider that addresses the steps that these devices cannot measure (e.g., uncapping the inhaler and holding the inhaler vertically), these devices can provide useful information about the patient's technique.
Feedback on inhaler technique is most commonly provided to patients in verbal format by their providers. Although provider feedback on technique, particularly teach-back instruction, is an effective teaching method, observational studies have documented that technique demonstrations occur in just 12% of office visits [14, 19, 20] . Low rates of inhaler technique instruction persist despite national guidelines that recommend inhaler technique skills should be demonstrated at every patient visit [36] . Perceived time constraints and the number of health topics that need to be addressed during a typical office visit could potentially limit providers' ability to engage in inhaler technique instruction. Additionally, new inhaler devices enter the market each year and providers may not receive training in how to use these devices, which can limit their comfort with instructing patients on proper technique. Thus, devices that provide automated technique feedback to patients could potentially enhance the ability of providers to provide technique education at every patient visit by reducing the amount of time necessary to assess patient's device technique. Repeated instruction is especially desirable given that deterioration in technique has been documented as early as 1 month after receiving technique education [13, 21, 37, 38] .
In addition to providing technique feedback in a time-efficient manner, inhaler technique devices can also provide tailored feedback to providers and patients on the specific steps that patients perform incorrectly. A large body of research has shown that tailored messages are more likely to be remembered and are more successful in influencing health behavior change than generic messages [39] [40] [41] . Specific to inhaler technique, one small pilot study found that videos that were tailored to patient demographic characteristics and the specific steps patients missed led to significant improvements in inhaler technique that were maintained at 1-month follow-up [42] . According to social cognitive theory, mastery experience (or doing something correctly) is the most effective way to foster self-efficacy [43, 44] . Thus, if patients are made aware of the specific inhaler steps that they perform incorrectly in real time, they can immediately correct those errors, which could increase their confidence to use their inhalers correctly (e.g., inhaler self-efficacy) and ultimately lead to better inhaler technique. There is also potential for these devices to improve patient inhaler technique in the home environment. Although none of these devices were intended for use outside of the clinical setting, daily feedback on inhaler technique may help ensure patients are using their inhalers correctly, especially for patients who receive a new prescription for an inhaler. In order to be feasible for home use, devices must be portable, affordable, and provide feedback to the patient in a user-friendly and understandable manner. Two of the devices described in this review used real-time feedback to incentivize correct inhaler use. This type of feedback may be especially helpful for helping new inhaler users master appropriate inhaler technique.
Based on our findings, we suggest three main areas for future directions for development and evaluation of inhaler technique assessment devices. The first is related to device development; the development of devices that are capable of assessing all essential steps for MDIs and non-diskus DPIs are warranted. Second, device developers should involve target users (i.e., patients, providers) in the design process to ensure that the feedback provided by the device is easily interpretable. Devices that provide feedback that is difficult to understand could limit device adoption and lower users' perceptions of the devices' utility [45] . Third, comparative effectiveness trials which evaluate the effectiveness of these devices at improving inhaler technique should be conducted. Such trials could compare the effectiveness of (1) devices compared to one another and (2) devices compared to provider instruction or multimedia instruction (e.g., videos).
Limitations
It is possible that we did not capture all devices in our search of the literature and patents. It is also possible that some of these devices described in this article are no longer commercially available. We did not include devices for which the primary purpose is to assess a patient's inspiratory flow rate or inspiratory capacity to identify the best dry powder inhaler for them, even though these devices have the capability to assess specific technique steps related to correct inhalation [21] . Detailed information regarding the specific technique steps assessed, target of feedback, and method for providing technique feedback was lacking for several of the devices. Although we attempted to contact the authors and/or manufacturers to obtain additional information, including information on cost, inadequate detail may have led us to inaccurately document specific aspects of the devices.
Conclusions
Inhaler technique, or competence, remains a relatively neglected area of patient education even though poor technique is associated with negative patient outcomes [11] [12] [13] . Many existing electronic devices focus on patient medication adherence, which is critical, but not sufficient, to improving asthma outcomes, since inappropriate technique can prevent medication from reaching the lungs [21] . Electronic devices can provide a time-efficient and reliable way for healthcare providers to assess patient inhaler technique. Existing devices can provide objective feedback about correct technique for steps that are difficult to assess with the naked eye, such as whether the patient inhaled forcefully enough or coordinated inhaler actuation with inhalation. Our review identifies several areas of opportunity to make inhaler technique devices useful in clinical care and home settings. Major areas for improvement include developing devices to assess technique for non-diskus DPI inhalers and improving the quality of technique feedback so it is quickly and easily interpretable by patients and providers. Future research should explore whether these devices can facilitate providers' ability to conduct inhaler technique assessments during office visits.
